Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Data Sharing During A Pandemic: EMBL-EBI’s COVID-19 Portal, GA4GH Take On Data Sharing

    Apr 23, 2020, 09:50 AM by Michael Croft
    Bio-IT World EMBL’s European Bioinformatics Institute (EMBL-EBI) has launched its COVID-19 Data Portal, which includes a wide range of data types including genomic, protein, and microscopy data, as well as scientific literature. The new data portal and others like it re-emphasize the importance of data sharing.
    Full story
  • Imvax Appoints Mark Exley, Ph.D. as Chief Scientific Officer

    Apr 23, 2020, 08:25 AM by Michael Croft
    PHILADELPHIA, PA, UNITED STATES - Apr 23, 2020 - Imvax, Inc., a clinical-stage biotechnology company, today announced that Mark Exley, PhD, has been appointed as Chief Scientific Officer (CSO)
    Full story
  • TraceLink Announces New Agile Solutions to Accelerate Digital Supply Chain Transformation; Allocates $1 Million Charitable Donation for COVID-19 Relief

    Apr 22, 2020, 11:50 AM by Michael Croft
    NORTH READING, MA, UNITED STATES - Apr 22, 2020 -  NORTH READING, MASS. (April 16, 2020) -TraceLink Inc., the leading digital platform company for the life sciences industry, today announced a new package of agile solutions designed to digitalize the pharmaceutical supply chain
    Full story
  • AskBio Acquires BrainVectis to Expand its Clinical Pipeline for Neurodegenerative Diseases

    Apr 22, 2020, 10:24 AM by Michael Croft
    RESEARCH TRIANGLE PARK, NC, US - Apr 22, 2020 - Asklepios BioPharmaceutical, Inc. (AskBio), a leading, clinical-stage adeno-associated virus (AAV) gene therapy company, today announced that it has acquired BrainVectis, a Paris-based gene therapy company and French National Institute for Health and Medical Research (INSERM) spin-out with expertise and an intellectual property estate for the treatment of neurodegenerative disorders
    Full story
  • Pharma Companies Poised To Go Digital, Starting With Field Reps

    Apr 22, 2020, 08:05 AM by Michael Croft

    Bio-IT World | It often takes a tragedy to trigger change and for pharma companies that tend to be digitally averse, the catalyst may well be the COVID-19 pandemic.

    Full story
  • Creative Biolabs Released Modotuximab for Research Use

    Apr 22, 2020, 01:55 AM by Michael Croft
    SHIRLEY, NY - Apr 22, 2020 - April 22, 2020, Creative Biolabs, as a leading supplier in recombinant antibody discovery and manufacturing, is equipped with cutting-edge hybridoma development and phage display platforms to be able to offer customers with high-quality and professional services
    Full story
  • InSysBio innovates its Immune Response Template Database

    Apr 21, 2020, 06:40 AM by Michael Croft
    MOSCOW, RUSSIA - Apr 15, 2020 - InSysBio is one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling has published the new version of IRT database, one of its core products
    Full story
  • Independent SMO Panthera Biopartners continues to expand its network of clinical trial sites

    Apr 20, 2020, 17:27 PM by Michael Croft
    PRESTON, UNITED KINGDOM - Apr 20, 2020 -  
    • Panthera's second clinical trial site in the UK, in North Manchester is open for business.
    • As a standalone site ideal for existing or new trials with much lower contamination risk during COVID-19
     Panthera is on track to have a network of sites open across the UK by the end of the year and is continuing to invest in growth despite the increasingly challenging environment created by the COVID-19 pandemic
    Full story
  • Solentim and ATUM to bundle Leap-In Transposase® with the VIPS™ single cell cloning instrument for cell line development

    Apr 20, 2020, 10:07 AM by Michael Croft
    BOURNEMOUTH, UK - Apr 20, 2020 - Solentim, a global leader in cell line development (CLD) instrumentation, and bioengineering company ATUM, today announced that Solentim will bundle access to the Leap-In Transposase® platform together with the Solentim VIPS™ single cell cloning instrument
    Full story
  • MicrofluidX raises £1.4m in seed funding to develop novel cell therapy bioprocessing technology

    Apr 20, 2020, 06:02 AM by Michael Croft
    LONDON, UNITED KINGDOM - Apr 20, 2020 - MicrofluidX announces it has raised £1.4m in seed funding from leading seed investors UK Innovation & Science Seed Fund (UKI2S), Longwall Ventures and Moulton Goodies Limited with angel contributions from 88 Capital and Cambridge Angels
    Full story
  • MDI Biological Laboratory Names New Faculty Member

    Apr 17, 2020, 12:13 PM by Michael Croft
    BAR HARBOR, ME, UNITED STATES - Apr 17, 2020 -   The MDI Biological Laboratory has announced that Prayag Murawala, Ph.D., has joined the faculty as an assistant professor
    Full story
  • IoT In The Lab Includes Digital Cages And Instrument Sensors

    Apr 17, 2020, 10:35 AM by Michael Croft

    Bio-IT World | Internet of Things measurement systems are effectively catapulting animal studies out of the horse-and-buggy era and eliminating preventable holdups due to instruments being out of date or incorrectly calibrated.

    Full story
  • ShanghaiTech University, NCC Group, And More: Bio-IT Community Continues Fight Against COVID-19

    Apr 17, 2020, 08:15 AM by Michael Croft

    Bio-IT World | The bio-IT community continues to aggressively research and innovate for SARS-CoV-2 solutions. The latest this week includes research on drug candidates, a SARS-CoV-2 gene map, free translation services for COVID-19 researchers, and much more.

    Full story
  • MDI Biological Laboratory-led Program Reveals High Arsenic in Well Water

    Apr 16, 2020, 11:21 AM by Michael Croft
    BAR HARBOR, ME, UNITED STATES - Apr 16, 2020 - A program to teach data literacy to Maine and New Hampshire students by analyzing data on arsenic in well water collected from their homes has found that 25 percent of samples exceed the New Hampshire maximum safety level of 5 parts per billion (ppb) and 15 percent exceed the U
    Full story
  • EPS Corporation Signs Groundbreaking Agreement to Drive Increased Quality and Safety Using CluePoints Risk-Based Quality Management Solution

    Apr 16, 2020, 04:42 AM by Michael Croft
    KING OF PRUSSIA, PA, US - Apr 16, 2020 - King of Prussia, PA  - April 14, 2020: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced that EPS have entered into an agreement with CluePoints to offer Risk Based Quality Management (RBQM) solutions to its sponsors to drive early risk detection, improve quality and enhance patient safety in a cost-effective and resource-efficient manner
    Full story
  • Biological Specialty Company Launches At-home Blood Donation Service for COVID-19 Patients Who Want to Help Develop New Drugs and Vaccines

    Apr 15, 2020, 08:48 AM by Michael Croft
    COLMAR, PA - Apr 15, 2020 - Biological Specialty Company (BSC) has launched an at-home blood donation service for COVID-19 positive patients
    Full story
  • Volunteer laboratory network launched to expand Covid-19 testing for key workers

    Apr 15, 2020, 08:07 AM by Michael Croft
    OXFORD, UNITED KINGDOM - Apr 15, 2020 -
    • The UK urgently needs to expand Covid-19 testing capacity for front-line healthcare workers
    • There are thousands of laboratories in the UK with the right equipment and expertise to run these tests - but they are currently not being used
    • SBL, a medical research laboratory in Oxfordshire, is already running 250-500 tests a week for local GPs, with same-day results
    • This project, launched and funded to £1M by Mike Fischer CBE, aims to build an emergency volunteer network of laboratories willing to convert to Covid-19 testing, to supplement the Government's existing facilities
    • A national network could deliver tens of thousands of additional tests per day
    The Covid-19 Volunteer Testing Network launched on 1st April 2020 to provide essential additional testing capacity to front-line workers
    Full story
  • NCC Group offers free cyber threat intelligence to global healthcare providers

    Apr 14, 2020, 17:16 PM by Michael Croft
    SAN FRANCISCO, CA - Apr 14, 2020 - NCC Group, the global cyber security and risk mitigation expert, is offering unique threat intelligence free of charge to national Computer Emergency Response Teams, hospitals and national institutes of public health around the world, for the next few months to help them build cyber resilience
    Full story
  • Scilligence Gives Back During the COVID-19 Pandemic

    Apr 14, 2020, 14:18 PM by Michael Croft
    CAMBRIDGE, MA, UNITED STATES - Apr 14, 2020 - While streets and stores may be empty during the COVID-19 outbreak, our hospitals are over capacity. The COVID-19 pandemic has resulted in an increase in patients and massive shortage in supplies for healthcare workers
    Full story
  • Clinically-proven gamification app teaches positive inhaler technique; crucial for managing asthma

    Apr 14, 2020, 13:41 PM by Michael Croft
    WILMSLOW, UNITED KINGDOM - Apr 14, 2020 -
    • The registered medical device can be downloaded for free[1].
    • Good inhaler technique and optimal control is especially crucial during the Covid-19 outbreakx
    Full story
  • «
  • 201
  • 202
  • 203
  • 204
  • 205
  • 206
  • 207 (current)
  • 208
  • 209
  • 210
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy